Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry-Reference-Cited by-同舟云学术

Comparison between treatment of “established” versus complex “off-label” coronary lesions with Absorb® bioresorbable scaffold implantation: results from the GABI-R® registry

Published:2019-06-29 Issue:3 Volume:109 Page:374-384
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Huseynov Aydin,Baumann Stefan,Nef Holger,Riemer Thomas,Schneider Steffen,Pfannenbecker Thomas,Achenbach Stephan,Mehilli Julinda,Münzel Thomas,Gori Tommaso,Wöhrle Jochen,Zahn Ralf,Kastner Johannes,Schmermund Axel,Richardt Gert,Hamm Christian W.,Akin Ibrahim

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-019-01517-8.pdf

Reference28 articles.

1. Onuma Y, Piazza N, Ormiston JA, Serruys PW (2009) Everolimus-eluting bioabsorbable stent—abbot vascular programme. EuroIntervention 5(Suppl F):F98–F102. https://doi.org/10.4244/eijv5ifa17

2. Garcia-Garcia HM, Gonzalo N, Pawar R, Kukreja N, Dudek D, Thuesen L, Ormiston JA, Regar E, Serruys PW (2009) Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention 4(4):443–448

3. Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hebert K, Veldhof S, Webster M, Thuesen L, Dudek D (2009) A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373(9667):897–910. https://doi.org/10.1016/S0140-6736(09)60325-1

4. Bauer T, Nienaber CA, Akin I, Kuck KH, Hochadel M, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Zahn R, Group DDS (2011) Comparison between on-label versus off-label use of drug-eluting coronary stents in clinical practice: results from the German DES.DE-Registry. Clin Res Cardiol 100(8):701–709. https://doi.org/10.1007/s00392-011-0301-8

5. Grines CL (2008) Off-label use of drug-eluting stents putting it in perspective. J Am Coll Cardiol 51(6):615–617. https://doi.org/10.1016/j.jacc.2007.10.028

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Impact of Lesion Complexity on 2-Year Outcomes After Zotarolimus-Eluting Stents Implantation;JACC: Asia;2021-12